Abhishek Datta
Soterix Medical, Inc. · Soterix Medical · Soterix Medical Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Abhishek Datta as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:09 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07287839 · Parcel-guided rTMS for Major Depressive DisorderSoterix Medical · not yet recruiting · Treatment Resistant Depression (TRD) · principal investigator
- Ph2NCT04994821 · TDCS to Reduce Craving in Cocaine Addiction- Phase 2 StudySoterix Medical · completed · Cocaine Use Disorder, Cocaine Dependence · principal investigator
- Ph1NCT04781127 · Home-administered tDCS for Treatment of DepressionSoterix Medical · completed · Unipolar Depression, Treatment Resistant Depression · principal investigator
- N/ANCT03833583 · TDCS for Cocaine Addiction CravingSoterix Medical · completed · Cocaine Use Disorder, Cocaine Dependence · principal investigator
- Ph2NCT02540109 · Targeted Electrotherapy for Aphasia Stroke Rehabilitation (TEASER) - Phase II Multi-Center StudySoterix Medical · completed · Chronic Aphasia · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- IGF::OT::IGF tDCS to Reduce Craving in Cocaine Addiction. Base Award. SBIR Phase I. September 30, 2018 - May 29, 2019. N43DA-18-8948.27120180003 · NIDA · SOTERIX MEDICAL,INC. · fiscal years 2018 · $476,864 awarded in 2018Same name and institution; not confirmed by an ID
- Targeted Transcranial Electrotherapy to accelerate Stroke Rehabilitation-Exploratory Trial on AphasiaR44NS092144 · NINDS · SOTERIX MEDICAL,INC. · fiscal years 2015 to 2018 · $504,558 awarded in 2018Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:09 UTC. The ranking covers the 200 most relevant of 46 PubMed records, and a shared surname and initials can bring in a namesake. All 46 on PubMed
- tDCS-induced analgesia and electrical fields in pain-related neural networks in chronic migraine.Headache · 2012219 citationsRCR 8.7
- 153 citationsRCR 6.4
- Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease.Ann Neurol · 2022141 citationsRCR 13.4
- Exposure to gamma tACS in Alzheimer's disease: A randomized, double-blind, sham-controlled, crossover, pilot study.Brain Stimul · 2021139 citationsRCR 11.0
- 125 citationsRCR 4.9
- 110 citationsRCR 5.6
- 105 citationsRCR 6.3
- Tolerability and feasibility of at-home remotely supervised transcranial direct current stimulation (RS-tDCS): Single-center evidence from 6,779 sessions.Brain Stimul · 202284 citationsRCR 8.9
- Generalizing remotely supervised transcranial direct current stimulation (tDCS): feasibility and benefit in Parkinson's disease.J Neuroeng Rehabil · 201875 citationsRCR 4.4
- Feasibility of using high-definition transcranial direct current stimulation (HD-tDCS) to enhance treatment outcomes in persons with aphasia.NeuroRehabilitation · 201569 citationsRCR 3.4